ask="34.47"
ask_size="100"
average_daily_volume="52120"
bid="N/A"
bid_size="N/A"
book_value="1.19"
change="-0.05"
change_from_200_day_moving_average="-1.14"
change_from_50_day_moving_average="-0.24"
change_from_52_week_high="-3.66"
change_From_52_week_low="0.30"
change_in_percent="-1.75%"
close="2.81"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.90"
ebitda="-15.74M"
eps_estimate_current_year="-3.71"
eps_estimate_next_quarter="-0.83"
eps_estimate_next_year="-3.33"
ex_dividend_date="N/A"
float_shares="5402000"
high="2.81"
high_52_weeks="6.47"
last_trade_date="2/22/2017"
last_trade_price="2.81"
last_trade_size="100"
last_trade_time="3:53pm"
low="2.72"
low_52_weeks="2.51"
market_capitalization="17.69M"
moving_average_200_day="3.95"
moving_average_50_day="3.05"
name="MABVAX THERAPEUTICS"
notes="N/A"
one_year_target_price="18.00"
open="2.76"
pe_ratio="N/A"
peg_ratio="-0.02"
percent_change_from_200_day_moving_average="-28.87%"
percent_change_from_50_day_moving_average="-7.82%"
percent_change_from_52_week_high="-56.60%"
percent_change_from_52_week_low="+11.78%"
previous_close="2.86"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.40"
price_per_sales="19.88"
revenue="905615.00"
shares_outstanding="6296000"
short_ratio="7.82"
stock_exchange="NCM"
symbol="MBVX"
volume="46775"
weeks_range_52="2.51 - 6.47"
